Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Express Pharma
Maharashtra FDA cancels Cipla C&F drug sale licences in Pune
The action follows inspections in June 2026 involving Reactin Plus Tablets, a Schedule H prescription medicine. The post Maharashtra FDA cancels Cipla C&F drug sale licences in Pune appeared first on Express Pharma.
Read Full Article
Pharma Tech
Myasthenia gravis market to reach $13.0bn across 7MM by 2034
The myasthenia gravis (MG) market across the 7MM is poised to grow at a CAGR of 11.1% from $4.5bn in 2024 to $13.0bn in 2034.
Read Full Article
Pharma Tech
Lilly’s Mounjaro wins US label expansion for cardiovascular risk reduction
The new Mounjaro approval will likely expand Lilly’s cardiometabolic empire as it looks to stay ahead of rival Novo Nordisk.
Read Full Article
PharmaShots
Top 20 Monoclonal Antibodies of 2026Â
Shots: 20. Proprietary Name: Taltz Non-Proprietary Name: Ixekizumab Company: Eli Lilly First Approved: US (Mar 22, 2016), EU (Apr 25, 2016)  Total Revenue: $3.56B 19. Proprietary Name: Perjeta Non-Proprietary Name: Pertuzumab Company: Roche First Approved: US (Jun 08, 2012), EU (Mar 04, 2013)  Total Revenue: $3.75B 18. Proprietary Name: Prolia Non-Proprietary Name: Denosumab Company: Amgen First Approved: US (Jun 01, 2010), EU (May 26, 2010)  Total Revenue: $4.41B 17. Proprietary… The post Top 20 Monoclonal Antibodies of 2026 appeared first on PharmaShots.
Read Full Article
Pharma Tech
FDA approves Priovant’s rare autoimmune therapy Lisraya in indication first
Priovant is now looking to roll out Lisraya, the first targeted therapy for dermatomyositis, across the US via specialty pharmacies.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Aug 31, 2026, 2:03 AM
Three held in fake BP drug racket; trail leads to Lucknow
The case came to light after J B Chemicals and Pharmaceuticals Ltd complained to the drug regulator on Aug 19 about circulation of counterfeit Nicardia Retard 10 (nifedipine sustained release tablets Img).
Express Pharma
Aug 29, 2026, 6:41 AM
Maharashtra FDA cancels Cipla C&F drug sale licences in Pune
The action follows inspections in June 2026 involving Reactin Plus Tablets, a Schedule H prescription medicine. The post Maharashtra FDA cancels Cipla C&F drug sale licences in Pune appeared first on Express Pharma.
Pharma Tech
Aug 28, 2026, 3:36 PM
Myasthenia gravis market to reach $13.0bn across 7MM by 2034
The myasthenia gravis (MG) market across the 7MM is poised to grow at a CAGR of 11.1% from $4.5bn in 2024 to $13.0bn in 2034.
Pharma Tech
Aug 28, 2026, 2:15 PM
Lilly’s Mounjaro wins US label expansion for cardiovascular risk reduction
The new Mounjaro approval will likely expand Lilly’s cardiometabolic empire as it looks to stay ahead of rival Novo Nordisk.
PharmaShots
Aug 28, 2026, 1:30 PM
Top 20 Monoclonal Antibodies of 2026Â
Shots: 20. Proprietary Name: Taltz Non-Proprietary Name: Ixekizumab Company: Eli Lilly First Approved: US (Mar 22, 2016), EU (Apr 25, 2016)  Total Revenue: $3.56B 19. Proprietary Name: Perjeta Non-Proprietary Name: Pertuzumab Company: Roche First Approved: US (Jun 08, 2012), EU (Mar 04, 2013)  Total Revenue: $3.75B 18. Proprietary Name: Prolia Non-Proprietary Name: Denosumab Company: Amgen First Approved: US (Jun 01, 2010), EU (May 26, 2010)  Total Revenue: $4.41B 17. Proprietary… The post Top 20 Monoclonal Antibodies of 2026 appeared first on PharmaShots.
PharmaShots
Aug 28, 2026, 12:30 PM
SOTIO Biotech Receives FDA Fast Track Designation for SOT106 to Treat Soft Tissue Sarcoma
Shots: Ref: Globenewswire |  Image: SOTIO Biotech | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post SOTIO Biotech Receives FDA Fast Track Designation for SOT106 to Treat Soft Tissue Sarcoma appeared first on PharmaShots.
News
Latest industry coverage
Google News
Aug 31, 2026, 4:17 AM
Consun Pharmaceutical Group And 2 Other Undiscovered Gems In Asia - simplywall.st
Consun Pharmaceutical Group And 2 Other Undiscovered Gems In Asia  simplywall.st
Google News
Aug 31, 2026, 4:16 AM
Fosun Pharma strengthens innovation pipeline as Henlius and global drug portfolio expand - BioSpectrum Asia
Fosun Pharma strengthens innovation pipeline as Henlius and global drug portfolio expand  BioSpectrum Asia
Google News
Aug 31, 2026, 4:07 AM
How America Can Reduce Its Dependence on Chinese Active Pharmaceutical Ingredients (APIs) - Information Technology and Innovation Foundation
How America Can Reduce Its Dependence on Chinese Active Pharmaceutical Ingredients (APIs)Â Â Information Technology and Innovation Foundation
Google News
Aug 31, 2026, 4:04 AM
China poses increasing security risk as US biotech innovation edge erodes - BioSpace
China poses increasing security risk as US biotech innovation edge erodes  BioSpace
Google News
Aug 31, 2026, 1:51 AM
China’s ahead in new pharma race: Own meds, don’t just make them - Asia Times
China’s ahead in new pharma race: Own meds, don’t just make them  Asia Times
Google News
Aug 31, 2026, 1:17 AM
Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) Passed Our Checks, And It's About To Pay A â‚ą4.00 Dividend - simplywall.st
Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) Passed Our Checks, And It's About To Pay A ₹4.00 Dividend  simplywall.st
Google News
Aug 30, 2026, 5:15 PM
Should Eli Lilly Investors Be Worried About a Threat From Amylyx? - The Motley Fool
Should Eli Lilly Investors Be Worried About a Threat From Amylyx?  The Motley Fool
Google News
Aug 30, 2026, 4:35 PM
Should Eli Lilly Investors Be Worried About a Threat From Amylyx? - Yahoo Finance
Should Eli Lilly Investors Be Worried About a Threat From Amylyx?  Yahoo Finance
Google News
Aug 30, 2026, 3:30 PM
Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia - Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia  Arrowhead Pharmaceuticals, Inc.
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer